InsiderTrades.com logo
China Stockpiling Gold “Like No Tomorrow”
From True Gold Republic   |   Ad
For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .
Click here now to get your free 'De-Dollarization' Guide.

TCRX Insider Trading

Insider Ownership Percentage: 2.76%
Insider Buying (Last 12 Months): $222,478.70
Insider Selling (Last 12 Months): $951,885.08

TScan Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at TScan Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TScan Therapeutics Share Price & Price History

Current Price: $5.55
Price Change: ▼ Price Decrease of -0.08 (-1.42%)
As of 09/6/2024 01:00 AM ET

This chart shows the closing price history over time for TCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Perfect Crypto Buying Opportunity for 50 Cents
From Crypto 101 Media   |   Ad
When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank
Go here to get full details on this crypto now.

TScan Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/26/2024Barbara KlenckeDirectorBuy5,000$5.53$27,650.0040,000View SEC Filing Icon  
8/23/2024Barbara KlenckeDirectorBuy5,000$5.69$28,450.0035,000View SEC Filing Icon  
8/23/2024Zoran ZdraveskiInsiderSell164,686$5.78$951,885.084,716View SEC Filing Icon  
12/18/2023Timothy J BarberichDirectorBuy28,830$4.89$140,978.7066,710View SEC Filing Icon  
12/14/2023Barbara KlenckeDirectorBuy5,000$5.08$25,400.0030,000View SEC Filing Icon  
6/2/2023Timothy J BarberichDirectorBuy37,880$2.63$99,624.4037,880View SEC Filing Icon  
5/31/2023Lynx1 Capital Management LpMajor ShareholderSell25,400$2.52$64,008.005,224,600View SEC Filing Icon  
12/27/2022Brian M. SilverCFOBuy2,842$1.50$4,263.0029,727View SEC Filing Icon  
5/18/2022David P SouthwellCEOBuy25,000$3.59$89,750.00171,569View SEC Filing Icon  
3/24/2022Brian M. SilverCFOBuy15,000$3.40$51,000.00View SEC Filing Icon  
9/23/2021Zoran ZdraveskiInsiderBuy4,716$7.48$35,275.68View SEC Filing Icon  
9/21/2021Brian M. SilverCFOBuy5,000$6.32$31,600.00View SEC Filing Icon  
9/20/2021Gavin MacBeathInsiderBuy4,943$6.22$30,745.46View SEC Filing Icon  
See Full Table
China Stockpiling Gold “Like No Tomorrow”
From True Gold Republic   |   Ad
For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .
Click here now to get your free 'De-Dollarization' Guide.

SEC Filings (Institutional Ownership Changes) for TScan Therapeutics (NASDAQ:TCRX)

82.83% of TScan Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TScan Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2024The Manufacturers Life Insurance Company 15,383$90K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/15/2024Troluce Capital Advisors LLC92,832$0.54M0.1%N/A0.176%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC940,831$5.50M1.1%N/A1.780%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP307,487$1.80M0.0%+60.8%0.582%Search for SEC Filing on Google Icon
8/14/2024Bank of Montreal Can120,454$0.75M0.0%N/A0.228%Search for SEC Filing on Google Icon
8/12/2024Marathon Trading Investment Management LLC13,600$80K0.0%-73.3%0.026%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC80,000$0.47M0.0%+70.2%0.151%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP11,882$70K0.0%N/A0.022%Search for SEC Filing on Google Icon
8/9/2024Brown Brothers Harriman & Co.76,024$0.45M0.0%N/A0.144%Search for SEC Filing on Google Icon
8/8/2024Cornercap Investment Counsel Inc.22,940$0.13M0.0%N/A0.043%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.47,481$0.28M0.0%+48.9%0.090%Search for SEC Filing on Google Icon
8/2/2024Privium Fund Management UK Ltd12,103$69K0.0%-23.5%0.023%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers46,867$0.27M0.0%N/A0.089%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp116,658$0.68M0.0%N/A0.221%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,808,152$14.36M0.0%+1.1%3.776%Search for SEC Filing on Google Icon
5/10/2024Tocqueville Asset Management L.P.212,200$1.69M0.0%N/A0.443%Search for SEC Filing on Google Icon
4/17/2024Cannon Global Investment Management LLC17,500$0.14M0.4%N/A0.037%Search for SEC Filing on Google Icon
2/14/2024Pale Fire Capital SE21,573$0.13M0.0%+30.2%0.045%Search for SEC Filing on Google Icon
2/12/2024Letko Brosseau & Associates Inc.20,700$0.12M0.0%-36.1%0.043%Search for SEC Filing on Google Icon
1/31/2024abrdn plc200,000$1.17M0.0%N/A0.418%Search for SEC Filing on Google Icon
11/14/2023Pale Fire Capital SE16,575$42K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/9/2023Letko Brosseau & Associates Inc.32,400$83K0.0%N/A0.068%Search for SEC Filing on Google Icon
8/15/2023BVF Inc. IL2,989,474$7.47M0.2%N/A12.338%Search for SEC Filing on Google Icon
8/10/2023Monashee Investment Management LLC400,000$1M0.2%N/A1.651%Search for SEC Filing on Google Icon
7/26/2023Privium Fund Management B.V.15,825$40K0.0%N/A0.065%Search for SEC Filing on Google Icon
5/10/2023Simplify Asset Management Inc.546,916$1.15M0.2%N/A2.257%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC514,655$0.80M0.1%-7.8%2.137%Search for SEC Filing on Google Icon
11/16/2022Alphabet Inc.1,077,080$3.29M0.2%N/A4.482%Search for SEC Filing on Google Icon
11/15/2022Tang Capital Management LLC557,915$1.70M0.2%-25.4%2.322%Search for SEC Filing on Google Icon
11/4/2022Prudential Financial Inc.11,000$34K0.0%N/A0.046%Search for SEC Filing on Google Icon
11/1/2022Privium Fund Management UK Ltd15,825$48K0.1%N/A0.066%Search for SEC Filing on Google Icon
5/17/2022RA Capital Management L.P.1,021,764$2.86M0.1%-18.6%4.299%Search for SEC Filing on Google Icon
5/17/2022Hhlr Advisors LTD.669,513$1.88M0.0%-47.8%2.817%Search for SEC Filing on Google Icon
4/26/2022Marquette Asset Management LLC28,895$81K0.0%+33.7%0.122%Search for SEC Filing on Google Icon
2/15/2022Deer Management Co. LLC1,245,505$5.61M0.1%N/A5.240%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.550,000$2.48M0.0%+10.8%2.314%Search for SEC Filing on Google Icon
1/19/2022Marquette Asset Management LLC21,618$97K0.0%N/A0.091%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC22,200$0.19M0.0%N/A0.093%Search for SEC Filing on Google Icon
11/16/2021Wellington Management Group LLP139,566$1.16M0.0%N/A0.582%Search for SEC Filing on Google Icon
11/15/2021RA Capital Management L.P.1,255,317$10.47M0.1%N/A5.238%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP75,000$0.63M0.0%N/A0.313%Search for SEC Filing on Google Icon
11/12/2021DC Investments Management LLC35,563$0.30M0.6%N/A0.148%Search for SEC Filing on Google Icon
11/12/2021DC Funds LP630,000$5.25M20.6%N/A2.629%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,500,577$12.52M0.0%N/A6.261%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC100,000$0.83M0.2%N/A0.417%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TScan Therapeutics logo
TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 that is in Phase I clinical trial for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. It also develops TSC-200, TSC-201, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors; and TSC-202 to treat solid tumors. In addition, the company develops vaccines for infectious diseases, such as SARS-CoV-2. It has collaborations with Novartis Institutes for BioMedical Research, Inc. To discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Read More on TScan Therapeutics

Today's Range

Now: $5.55
Low: $5.47
High: $5.72

50 Day Range

MA: $6.21
Low: $5.39
High: $7.49

52 Week Range

Now: $5.55
Low: $2.35
High: $9.69

Volume

216,785 shs

Average Volume

211,924 shs

Market Capitalization

$293.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of TScan Therapeutics?

TScan Therapeutics' top insider shareholders include:
  1. Lynx1 Capital Management Lp (Major Shareholder)
  2. Timothy J Barberich (Director)
  3. Barbara Klencke (Director)
  4. Brian M Silver (CFO)
  5. Zoran Zdraveski (Insider)
Learn More about top insider investors at TScan Therapeutics.

Who are the major institutional investors of TScan Therapeutics?

TScan Therapeutics' top institutional investors include:
  1. Great Point Partners LLC — 1.78%
  2. Marshall Wace LLP — 0.58%
  3. Bank of Montreal Can — 0.23%
  4. Bank of New York Mellon Corp — 0.22%
  5. Troluce Capital Advisors LLC — 0.18%
  6. Renaissance Technologies LLC — 0.15%
Learn More about top institutional investors of TScan Therapeutics stock.

Which major investors are selling TScan Therapeutics stock?

In the previous quarter, TCRX stock was sold by these institutional investors:
  1. Marathon Trading Investment Management LLC
  2. Privium Fund Management UK Ltd

Which major investors are buying TScan Therapeutics stock?

In the last quarter, TCRX stock was acquired by institutional investors including:
  1. Great Point Partners LLC
  2. Bank of Montreal Can
  3. Bank of New York Mellon Corp
  4. Marshall Wace LLP
  5. Troluce Capital Advisors LLC
  6. Brown Brothers Harriman & Co.
  7. Rhumbline Advisers
  8. Renaissance Technologies LLC
Within the previous year, these company insiders have bought TScan Therapeutics stock:
  1. Lynx1 Capital Management Lp (Major Shareholder)
  2. Timothy J Barberich (Director)
  3. Barbara Klencke (Director)
Learn More investors buying TScan Therapeutics stock.
China Stockpiling Gold “Like No Tomorrow”
From True Gold Republic   |   Ad
For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times. China, a rising global economic threat, aims to reduce its dependence on the US dollar… .
Click here now to get your free 'De-Dollarization' Guide.